News
The National Legal and Policy Center, a right-wing advocacy and watchdog group, had asked the company to revisit its DEI ...
Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...
DES MOINES, Iowa, Jan. 7, 2025 /PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2025 selections for the industry's most promising up-and-coming companies.
The recognition from BioSpace, a life sciences industry news outlet and career hub, highlights top up-and-coming biopharmaceutical companies to watch in the new year. “We are pleased to be a ...
West Harlem-based biotech incubator Harlem Biospace—which received $9 million in state funding last year—has entered the planning stages of construction. The new lab, which will be built by the Harlem ...
--(BUSINESS WIRE)--Mammoth Biosciences, Inc., a biotech company harnessing next-generation CRISPR technology to cure and detect disease, today announced its recognition as a BioSpace 2023 Best ...
The listing, posted on social media this week by brokers with CBRE, is for a project called BioSpace. Five life sciences trends to watch for in 2023 Sacramento-area startups are finding funding ...
The campaign promotes life science organizations within Oregon, Washington, Idaho and Montana as well as those in the provinces of Alberta, British Columbia, Manitoba and Saskatchewan. Each ...
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)-- EOS imaging (www.eos-imaging.com) announced today that it is retiring the corporate name ‘biospace med’ and will now officially be known as ‘EOS ...
In a move expected to impact around 100 employees, Astellas Gene Therapies is closing its Eccles biomanufacturing facility in South San Francisco, BioSpace first reported. While the fate of all ...
Harlem Biospace, which launched in November, offers its clients lab space for projects with rents at $995 per desk monthly. The city’s Economic Development Corporation, which financed Harlem ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results